Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB
Follow-up of Clinical Manifestations and Inflammation-related Parameters in Individuals with Autoantibodies Against Ro/SSA and La/SSB
Karolinska Institutet
500 participants
Feb 9, 2024
OBSERVATIONAL
Conditions
Summary
In this study, individuals with autoantibodies against Ro/SSA and La/SSB will be followed with regard to clinical manifestations and immunological parameters to identify immunological changes, environmental factors, and early clinical symptoms that characterize the progression from serological autoreactivity to clinically manifest disease.
Eligibility
Inclusion Criteria4
- To be included in the risk group, the following criteria must be met:
- \- At least one instance of testing positive for Ro/SSA or La/SSB, regardless of the method used.
- To be included in the control group, the individual must:
- \- Have no rheumatologic disease and no autoantibodies against Ro/SSA or La/SSB.
Exclusion Criteria4
- Below 18 years of age
- Inability to consent to their own participation
- Ongoing infection or severe illness where the study physician deems participation in the study not to be in the individuals best interest
- Inability to read and understand Swedish, and therefore unable to complete the forms and questionnaires included in the project
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06594861